Skip to main content

Find Clinical Trials

Home
Conditions
Hepatocellular Carcinoma (HCC)

Clinical trial condition

Hepatocellular Carcinoma (HCC)

Explore clinical trials studying Hepatocellular Carcinoma (HCC). Study availability and eligibility vary by location and protocol.

230 public trials 90 recruiting studies

Refine in advanced search Browse all conditions

Hepatocellular Carcinoma (HCC) trial results

Not Yet Recruiting

The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma

NCT06750159

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

NCT06724263

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +46 more
Locations: Shanghai East Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Sequential T and I With H101 Via HAI for BCLC C Stage HCC: A Prospective Single-Center Single-Arm Pilot Study

NCT06685354

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Not Yet Recruiting

CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma

NCT06641453

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Biotherapeutic Department of Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Therapeutic Effects of Immuno-targeted Therapy Combined With or Without RT for HCC

NCT06639971

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Completed

HCC-MPDS Multimodal Deep Learning Prognostic Model for Resectable HCC

NCT07700082

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China

View Trial Details

Completed

Estimation and Prediction of Individual Benefit From Postoperative Adjuvant Transcatheter Arterial Chemoembolization For Patients With Hepatocellular Carcinoma

NCT07562763

Conditions: Adenocarcinoma, Adjuvant Therapy, Carcinoma, +13 more
Locations: The First Affiliated Hospital of USTC Hefei, Anhu, China

View Trial Details

Completed

Non-Invasive Risk Stratification for Hepatocellular Carcinoma in HCV-Related Compensated Advanced Chronic Liver Disease Following Sustained Virological Response: Validation of the aMAP Score

NCT07687758

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +20 more
Locations: Siriraj Hospital Bangkok, Thailand

View Trial Details

Completed

Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone

NCT02562755

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations: University of Alabama Birmingham, Alabama, United States

Mayo Clinic Arizona Scottsdale, Arizona, United States

UC Irvine Medical Center Orange, California, United States

Stanford University School of Medicine Palo Alto, California, United States

View all 142 locations

View Trial Details

Completed

Multimodal Machine Learning Characterization of Solid Tumors

NCT04687969

Conditions: Adenocarcinoma, Adenocarcinoma of Prostate, Carcinoma, +33 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details